What to expect at the
New Product Planning Summit

 

The New Product Planning Summit is the leading conference for defining how the new product planning role and related functions make informed, value-based, data-driven decisions about products in the pipeline.

Life science industry professionals gather here each year to consider how and when to utilize various resources and ask the right questions to ensure commercial success. Now in its fifth year, the New Product Planning Summit has the largest and most diverse speaking faculty yet, allowing us to cover in-depth topics benefiting drug, biotech, and device manufacturers of all different sizes. Our new virtual structure allows you to submit questions to speakers during live Q&A, network with colleagues in structured zoom breakout rooms, and view sessions on-demand up to 6 months after.

Join us in February 2021 to become a part of this growing community of eager professionals who are navigating the New Product Planning space during these uncertain times.

Key Learnings

  • Determine optimal timing to collaborate with market research, competitive intelligence, pricing, market access, and medical affairs for successful commercial launch based on development stage and probability of success
  • Prioritize your product pipeline by analyzing crucial scientific and commercial variables
  • Discuss the implications of the how the pandemic is affecting scenario planning and forecasting
  • Consider the differences in new product planning for cell therapies, non-cell therapies, and gene therapies
  • Hear how life science companies are factoring companion diagnostics and digital aids into their product plans

 Who Attends

This conference attracts SVPs, VPs, Directors, Heads and Managers from the pharmaceutical and biotechnology industries whose responsibilities include:

  • New Product Planning/Commercialization/Development
  • Competitive/Business Intelligence
  • Business/Strategic Planning
  • Product Development
  • Publication Planning
  • Brand Commercialization
  • Market Access/Pricing
  • Medical Strategy
  • Medical Affairs
  • Scientific/Medical Communication
  • Managed Markets/Care Strategy
  • Licensing
  • Commercial Assessment/Strategy
  • Market Research
  • Global/Strategic Marketing
  • Portfolio/Product/Brand/Lifecycle Management
  • Research and Development
  • Health Economics and Outcomes Research
  • Reimbursement Strategy
  • Regulatory Affairs/Compliance
  • Intellectual Property/Legal
  • Publication Planning
  • Business Development

     

 Past Participants of the New Product Planning Summit Include

  • Akebia Therapeutics
  • Alexion Pharmaceuticals
  • Alkermes
  • BeiGene
  • Boston Pharmaceuticals
  • Celgene
  • Daiichi Sankyo
  • Emergent BioSolutions
  • Genentech
  • Heron Therapeutics
  • Indegene
  • Kyowa Kirin Pharmaceutical Development
  • LEO Pharma
  • Lundbeck
  • Otsuka
  • Sanofi Genzyme
  • Theravance Biopharma
  • United Therapeutics